Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required

Am J Hematol. 2021 Sep 1;96(9):E338-E339. doi: 10.1002/ajh.26257. Epub 2021 Jun 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Central Nervous System
  • Central Nervous System Neoplasms* / drug therapy
  • Central Nervous System Neoplasms* / prevention & control
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Methotrexate / adverse effects
  • Neoplasm Recurrence, Local
  • Retrospective Studies

Substances

  • Methotrexate